KANK1-TPD52L3 Fusion FISH Probe
The KANK1-TPD52L3 Fusion FISH Probe is used to confirm a fusion of the KANK1 and TPD52L3 genes. The fusion of the KANK1 and TPD52L3 genes has been associated with Kidney Renal Clear Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| KANK1-TPD52L3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| KANK1-TPD52L3-20-AQAQ | 20 (40 μL) | 200 μL |
|
KANK1 Gene Summary
The protein encoded by this gene belongs to the Kank family of proteins, which contain multiple ankyrin repeat domains. This family member functions in cytoskeleton formation by regulating actin polymerization. This gene is a candidate tumor suppressor for renal cell carcinoma. Mutations in this gene cause cerebral palsy spastic quadriplegic type 2, a central nervous system development disorder. A t(5;9) translocation results in fusion of the platelet-derived growth factor receptor beta gene (PDGFRB) on chromosome 5 with this gene in a myeloproliferative neoplasm featuring severe thrombocythemia. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 20. [provided by RefSeq, Dec 2014]
Gene Name: KN Motif And Ankyrin Repeat Domains 1
Chromosome: CHR9: 504702 -746103
Locus: 9p24.3
TPD52L3 Gene Summary
This gene encodes a member of the tumor protein D52-like family of proteins. These proteins are characterized by an N-terminal coiled-coil motif that is used to form homo- and heteromeric complexes with other tumor protein D52-like proteins. The encoded protein may play a role in spermatogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Gene Name: Tumor Protein D52 Like 3
Chromosome: CHR9: 6328348 -6331900
Locus: 9p24.1
Gene Diseases
The KANK1 TPD52L3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Kidney Renal Clear Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|